Literature DB >> 21053414

Xpert TB diagnostic highlights gap in point-of-care pipeline.

Kelly Morris.   

Abstract

Mesh：

Year:  2010        PMID： 21053414     DOI： 10.1016/s1473-3099(10)70231-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.

Authors:  Gabriel M Cohen; Paul K Drain; Farzad Noubary; Christie Cloete; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

Review 2.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

3.  Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa.

Authors:  Kathryn Schnippel; Gesine Meyer-Rath; Lawrence Long; William MacLeod; Ian Sanne; Wendy S Stevens; Sydney Rosen
Journal:  Trop Med Int Health       Date:  2012-06-12       Impact factor: 2.622
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.